3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor
Conditions
Breast Neoplasms
58
Ovarian Neoplasms
7
Neoplasm Metastasis
7
Endometrial Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Neoplasms
4
Hereditary Sensory and Autonomic Neuropathies
4
Advanced Breast Cancer
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Colorectal Neoplasms
3
Neoplasms by Site
2
Head and Neck Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Breast Diseases
2
Advanced Solid Tumors
2
Advanced Solid Tumor
2
Unilateral Breast Neoplasms
1
Spinocerebellar Degenerations
1
Salivary Gland Neoplasms
1
Recurrence
1
Prostatic Neoplasms
1
Melanoma
1
Lung Neoplasms
1
Locoregional Recurrence
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
HR+/HER2- Breast Cancer
1
HR+ Breast Cancer
1
Interventions
pembrolizumab
20
Gemcitabine
18
Cisplatin
14
Magnetic Resonance Spectroscopy
13
enfortumab vedotin
12
Specimen Handling
10
Cystectomy
10
Docetaxel
8
Mitomycin
7
Standard of Care
6
Cystoscopy
6
Transurethral Resection of Bladder
5
Radiotherapy
5
Carboplatin
5
durvalumab
4
Practice Guidelines as Topic
4
Nivolumab
4
Radiation
3
Multiparametric Magnetic Resonance Imaging
3
Mitozytrex
3
Fluorouracil
3
tislelizumab
2
dehydroftorafur
2
cemiplimab
2
avelumab
2
alvimopan
2
Therapeutics
2
Surveys and Questionnaires
2
Surgical Procedures, Operative
2
Radiosurgery
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recruiting
×
Urinary Bladder Neoplasms
×
Fulvestrant
×
Clear all
No trials found.